Purinergic P2Y2 receptors modulate endothelial sprouting

Cell Mol Life Sci. 2020 Mar;77(5):885-901. doi: 10.1007/s00018-019-03213-2. Epub 2019 Jul 5.

Abstract

Purinergic P2 receptors are critical regulators of several functions within the vascular system, including platelet aggregation, vascular inflammation, and vascular tone. However, a role for ATP release and P2Y receptor signalling in angiogenesis remains poorly defined. Here, we demonstrate that blood vessel growth is controlled by P2Y2 receptors. Endothelial sprouting and vascular tube formation were significantly dependent on P2Y2 expression and inhibition of P2Y2 using a selective antagonist blocked microvascular network generation. Mechanistically, overexpression of P2Y2 in endothelial cells induced the expression of the proangiogenic molecules CXCR4, CD34, and angiopoietin-2, while expression of VEGFR-2 was decreased. Interestingly, elevated P2Y2 expression caused constitutive phosphorylation of ERK1/2 and VEGFR-2. However, stimulation of cells with the P2Y2 agonist UTP did not influence sprouting unless P2Y2 was constitutively expressed. Finally, inhibition of VEGFR-2 impaired spontaneous vascular network formation induced by P2Y2 overexpression. Our data suggest that P2Y2 receptors have an essential function in angiogenesis, and that P2Y2 receptors present a therapeutic target to regulate blood vessel growth.

Keywords: Angiogenesis; Endothelial; P2Y2; Purinergic; Sprouting; Tip cell.

MeSH terms

  • Angiopoietin-2 / biosynthesis
  • Antigens, CD34 / biosynthesis
  • Cells, Cultured
  • Endothelial Cells / metabolism*
  • Endothelium, Vascular / growth & development*
  • Humans
  • Mitogen-Activated Protein Kinase 1 / biosynthesis
  • Mitogen-Activated Protein Kinase 3 / biosynthesis
  • Neovascularization, Physiologic / physiology*
  • Phosphorylation / physiology
  • Platelet Aggregation / physiology
  • Purinergic P2Y Receptor Antagonists / pharmacology
  • RNA Interference
  • RNA, Small Interfering / genetics
  • Receptors, CXCR4 / biosynthesis
  • Receptors, Purinergic P2Y2 / genetics
  • Receptors, Purinergic P2Y2 / metabolism*
  • Vascular Endothelial Growth Factor Receptor-2 / biosynthesis

Substances

  • Angiopoietin-2
  • Antigens, CD34
  • CXCR4 protein, human
  • Purinergic P2Y Receptor Antagonists
  • RNA, Small Interfering
  • Receptors, CXCR4
  • Receptors, Purinergic P2Y2
  • KDR protein, human
  • Vascular Endothelial Growth Factor Receptor-2
  • MAPK1 protein, human
  • MAPK3 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3

Grants and funding